Serum miRNA maker assemblage for detecting nonalcoholic fatty liver, and its application
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- 镇江市第三人民医院
- Publication Date
- 2015-01-21
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention relates to the field of biological technology, and relates to a combination and application of serum miRNA markers for distinguishing non-alcoholic fatty liver from normal people. Background technique
[0002] Nonalcoholic fatty liver disease (NAFLD) refers to a clinicopathological syndrome characterized by diffuse bullous steatosis in hepatocytes, excluding excessive alcohol consumption and other definite liver damage factors. A large number of epidemiological studies have shown that NAFLD has become a common chronic liver disease with a global trend. With the increase of obesity and related metabolic disorders, the prevalence of NAFLD in my country has increased rapidly in the past 10 years. Liver histological examination is still the gold standard for the diagnosis of NAFLD, but the side effects and limitations of liver biopsy often restrict the development of this diagnostic technique. Therefore, finding new diagnostic markers and n...